Further characterization of clinical and laboratory features in VEXAS syndrome: large‐scale analysis of a multicentre case series of 116 French patients*Sophie Georgin‐Lavialle, Thomas Cluzeau, Achille Aouba et al.|British Journal of Dermatology|2021Cited by 414
The Lymphoid Variant of Hypereosinophilic SyndromeGuillaume Lefèvre, Jean‐Emmanuel Kahn, Marie‐Christine Copin et al.|Medicine|2014Cited by 122
Serious infections in patients with VEXAS syndrome: data from the French VEXAS registryBenjamin De Valence, Mikaël Ebbo, M. Delaune et al.|Annals of the Rheumatic Diseases|2023Cited by 70
Daratumumab is effective in the relapsed or refractory systemic light‐chain amyloidosis but associated with high infection burden in a frail real‐life populationZoé Van de Wyngaert, Eileen M. Boyle, Benjamin Carpentier et al.|British Journal of Haematology|2019Cited by 29
Disseminated Infection Caused by<i>Francisella philomiragia</i>, France, 2014Louis Kreitmann, Nadine Lemaître, Louis Terriou et al.|Emerging infectious diseases|2012Cited by 24